Clinton AIDS Vaccine Call "A Recipe For Disaster"

25 May 1997

US President Bill Clinton's challenge to drugmakers last week to get anAIDS vaccine onto the market within 10 years is "a recipe for disaster, where government scientists and drug companies are pressured to 'fix' a problem with a solution more based on good politics than good science," according to Barbara Loe Fisher, president of the National Vaccine Information Center, a consumer watchdog organization.

Speaking at Morgan State University, Baltimore, Pres Clinton had said: "if the last 50 years were the age of physics, the next 50 years will be the age of biology." He urged a new national goal to be set in the "age of biology," stating: "today let us commit ourselves to developing an AIDS vaccine within the next decade."

Ms Fisher suggested that Department of Health and Human Services advisors may have failed to inform Pres Clinton completely about the biological impediments and dangers associated with injecting DNA into humans via a genetic vaccine. She added: "America and the world cannot afford to make a mistake on this one. There is a real danger of creating greater harm with an AIDS vaccine that is rushed to market in a vacuum of scientific knowledge than the harm we are already experiencing with AIDS in its current form."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight